Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D003000:Clonidine / Q000494:pharmacology; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D004357:Drug Synergism; D005106:Exploratory Behavior / Q000187:drug effects*; D005260:Female; D006321:Heart / Q000187:drug effects; D006719:Homovanillic Acid / Q000378:metabolism; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism*; D009929:Organ Size; D011339:Probenecid / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013268:Stimulation, Chemical; D013974:Thyroxine / Q000494:pharmacology*; D014316:Tritium; D014443:Tyrosine / Q000097:blood / Q000378:metabolism
D011941:Receptors, Adrenergic; D014316:Tritium; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D003000:Clonidine; D011339:Probenecid; D013974:Thyroxine; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid